Filing Details

Accession Number:
0001593968-18-001578
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-12-12 16:06:31
Reporting Period:
2018-12-10
Accepted Time:
2018-12-12 16:06:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
887359 Vericel Corp VCEL Biological Products, (No Disgnostic Substances) (2836) 943096597
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1235644 J Gerard Michel C/O Vericel Corporation
64 Sidney Street
Cambridge MA 02139
Cfo And Vp, Corp. Development No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-12-10 10,000 $1.95 160,960 No 4 M Direct
Common Stock Acquisiton 2018-12-10 5,625 $2.65 166,585 No 4 M Direct
Common Stock Disposition 2018-12-10 10,000 $16.81 156,585 No 4 S Direct
Common Stock Disposition 2018-12-10 5,625 $16.81 150,960 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2018-12-10 5,625 $0.00 5,625 $2.65
Common Stock Stock Option (right to buy) Disposition 2018-12-10 10,000 $0.00 10,000 $1.95
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
24,375 2027-05-22 No 4 M Direct
25,000 2026-02-09 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2018.
  2. 6.25% of these options, representing the right to purchase a total of 30,000 shares, became exercisable immediately on May 22, 2017. An additional 6.25% became exercisable on August 8, 2017 and continue to vest in equal quarterly installments from August 8, 2017, contingent upon the continued service to the Company.
  3. These options, representing the right to purchase a total of 80,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 9, 2016, which was one quarter after the date on which the option was granted.